Results 11 to 20 of about 65,034 (304)

Cutaneous leishmaniasis mimicking cutaneous lymphoma [PDF]

IDCases, 2019
Cutaneous leishmaniasis (CL) is caused by protozoa of Leishmania genus that are transmitted to humans through the bite of sand flies (Lutzomyia and Phlebotomus). The infection is classically manifested as multiple or single ulcers affecting cutaneous and/
Carla Andréa Avelar Pires, Nathalia Gabay Pereira, Amanda Gabay Moreira, Julie Marie Costa Sena, Caio César Chaves Costa, Thalita dos Santos Bastos, Fernanda do Nascimento Rodrigues, Evelyn de Paiva Faustino, Jéssica Rayanne Corrêa da Silva, Maria Amélia Lopes dos Santos   +9 more
doaj   +5 more sources

A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma

Case Reports in Dermatological Medicine, 2020
Cutaneous B-cell lymphomas (CBCL) are rare heterogeneous neoplastic diseases composing about 22.5% of all cutaneous lymphomas. These diseases can be divided into primary and secondary cutaneous variants with primary cutaneous B-cell lymphoma (PCBCL ...
Mary Awad, Erik Holzwanger, Sandeep Jubbal   +2 more
doaj   +3 more sources

Epidemiology of cutaneous lymphoma [PDF]

British Journal of Dermatology, 2021
Linked Article: Dobos et al. Br J Dermatol 2021; 184:1059–1067.
Vermeer M.
openaire   +3 more sources

Cutaneous Lymphoma Associated with JAK Inhibitors: A Pharmacovigilance Analysis of the FAERS Database and Literature Review [PDF]

Acta Dermato-Venereologica
The increasing use of JAK inhibitors in clinical practice is raising concerns regarding the potential risk of cutaneous lymphoma. This study aimed to conduct a comprehensive search for cases of cutaneous lymphoma associated with JAK inhibitors in the ...
Lu Lu, Jindi Feng, Huimin He, Yubin Peng, Shiyu Zhang, Lu Yang, Yuehua Liu, Tao Wang   +7 more
doaj   +2 more sources

Hodgkin's Lymphoma with Cutaneous Involvement

Middle East Journal of Cancer, 2016
Cutaneous Hodgkin’s lymphoma is a rare disease (0.5% to 3.4%) which tends to be in the setting of an advanced disease and has a poor prognosis. Treatment of patients with cutaneous involvement of Hodgkin’s lymphoma is according to dissemination of ...
Ahmad Ameri, Ainaz Sourati
doaj   +1 more source

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?

Cells, 2023
Extracorporeal photopheresis (ECP) is an FDA-approved immunotherapy for cutaneous T-cell lymphoma, which can provide a complete response in some patients. However, it is still being determined who will respond well, and predictive biomarkers are urgently
Oleg E. Akilov
doaj   +1 more source

Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma

Cells, 2022
The loss of CD47 on aging cells serves as a signal to macrophages to eliminate the target. Therefore, CD47 is a “do-not-eat-me” sign preventing macrophagal phagocytosis via interaction with its ligand SIRPα. Malignant lymphocytes of mycosis fungoides and
Amy Xiao, Oleg E. Akilov
doaj   +1 more source

Cutaneous Involvement of Extranodal NK/T Cell Lymphoma, Nasal Type, a Clinical and Histopathological Mimicker of Various Skin Diseases

Dermatopathology, 2022
Background: Extranodal NK/T cell lymphoma, nasal type (ENK/T) with cutaneous involvement has various histopathological findings and diverse clinical manifestations.
Preeyawat Ngamdamrongkiat, Sanya Sukpanichnant, Manasmon Chairatchaneeboon, Archrob Khuhapinant, Panitta Sitthinamsuwan   +4 more
doaj   +1 more source

Reliable blood cancer cells' telomere length evaluation by qPCR

Cancer Medicine, 2020
Background Telomere shortening is linked to a range of different human diseases, hence reliable measurement methods are needed to uncover such associations.
Joana Ropio, Alain Chebly, Jacky Ferrer, Martina Prochazkova‐Carlotti, Yamina Idrissi, Lamia Azzi‐Martin, David Cappellen, Anne Pham‐Ledard, Paula Soares, Jean‐Philippe Merlio, Edith Chevret   +10 more
doaj   +1 more source

Cutaneous Lymphomas — Part II: Other Cutaneous Lymphomas

Actas Dermo-Sifiliográficas (English Edition), 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides, Sézary syndrome, and lymphoproliferative CD30+ disorders are few, accounting for less than 5% of all cutaneous lymphomas. A cytotoxic phenotype is characteristic of these tumors, and their clinical behavior is usually aggressive.
R M, Pujol, F, Gallardo
openaire   +2 more sources